COVID-19: Risiko für Patienten mit chronisch entzündlichen Erkrankungen?

Evgenia Makrantonaki
{"title":"COVID-19: Risiko für Patienten mit chronisch entzündlichen Erkrankungen?","authors":"Evgenia Makrantonaki","doi":"10.1159/000514081","DOIUrl":null,"url":null,"abstract":"COVID-19, caused by the SARS-CoV-2 virus, has become pandemic. With sharply rising infection rates, patient groups characterized by an enhanced infection risk will be challenged by the virus. In this context, patients with chronic immune-mediated inflammatory diseases are of particular interest, as these diseases are characterized by an intrinsic immune dysfunction leading to inflammation that may enhance risk for severe infection.","PeriodicalId":501344,"journal":{"name":"Karger Kompass Dermatologie","volume":"51 1","pages":"9-11"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Karger Kompass Dermatologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000514081","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

COVID-19, caused by the SARS-CoV-2 virus, has become pandemic. With sharply rising infection rates, patient groups characterized by an enhanced infection risk will be challenged by the virus. In this context, patients with chronic immune-mediated inflammatory diseases are of particular interest, as these diseases are characterized by an intrinsic immune dysfunction leading to inflammation that may enhance risk for severe infection.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
引发慢性疾病的风险?
由SARS-CoV-2病毒引起的COVID-19已成为大流行。随着感染率急剧上升,感染风险较高的患者群体将面临病毒的挑战。在这种情况下,慢性免疫介导炎症性疾病的患者特别感兴趣,因为这些疾病的特点是内在免疫功能障碍导致炎症,可能增加严重感染的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Off-Label Use: Ruxolitinib im Einsatz bei entzündlichen Hauterkrankungen COVID-19: Risiko für Patienten mit chronisch entzündlichen Erkrankungen? Metastasiertes Melanom: Immuntherapie für Patienten ohne Krankheitsnachweis Transhumanismus: Welchen Menschen wollen wir? Wissenschaftlicher Beirat / Impressum / Inhalt
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1